Michael Wolberg

Title: Michael Wolberg: Innovator in Pharmaceutical Processes

Introduction

Michael Wolberg is a notable inventor based in Neutraubling, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for producing chemical compounds. With a total of 7 patents to his name, Wolberg's work has had a considerable impact on the industry.

Latest Patents

Wolberg's latest patents include a process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives. This invention focuses on a new method for producing these derivatives, specifically 2-[2-(3-butoxyphenyl)-ethylamino]-N,N-dimethylacetamide, with high yields and exceptional chemical purity. Another significant patent involves a process for preparing diol sulfones, which includes the reaction of a halomethyl substrate with a thio-aryl compound to obtain a thio-ether compound. This thio-ether compound is then oxidized to yield the corresponding sulfone, which can serve as a building block for statin-type compounds.

Career Highlights

Throughout his career, Michael Wolberg has worked with various companies, including Rigel Pharmaceuticals and Dpx Holdings. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical sector.

Collaborations

Wolberg has collaborated with notable colleagues such as Karl-Heinz Giselbrecht and Ulfried Felfer. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in the field of pharmaceuticals.

Conclusion

Michael Wolberg's contributions to the pharmaceutical industry through his innovative processes and collaborations highlight his role as a significant inventor. His work continues to influence the development of new chemical compounds and processes, showcasing the importance of innovation in this field.